Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app aims to reduce pregnancy risks from hypertension and diabetes

NCT ID NCT07243886

Not yet recruiting Disease control Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a mobile app (MOM-HD) can help pregnant women with high blood pressure or diabetes monitor their blood pressure and blood sugar at home. About 864 women in Nepal will either use the app plus standard care or standard care alone. The goal is to see if home monitoring leads to better health outcomes for mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mobile app-based telemonitoring program (MOM-HD) with blood pressure monitor and/or glucometer
What this could lead to
If successful, this could provide a cost-effective way to manage pregnancy complications like high blood pressure and diabetes at home, potentially reducing risks for mothers and babies.
What could go wrong
This is an early-stage trial in Nepal, and results may not apply to other settings. The app relies on consistent smartphone use and daily monitoring, which may be challenging for some participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes hypertension, pregnancy-induced hypertensive disorder mild pre-eclampsia Toxemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES HYPERTENSIVE DISORDER OF PREGNANCY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.